• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实施全州范围针对新疾病的新生儿筛查:美国项目经验

Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences.

作者信息

Kellar-Guenther Yvonne, McKasson Sarah, Hale Kshea, Singh Sikha, Sontag Marci K, Ojodu Jelili

机构信息

Center for Public Health Innovation, CI International, Littleton, CO 80120, USA;

Department of Community and Behavioral Health, Colorado School of Public Health, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA.

出版信息

Int J Neonatal Screen. 2020 Apr 30;6(2):35. doi: 10.3390/ijns6020035. eCollection 2020 Jun.

DOI:10.3390/ijns6020035
PMID:33073030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7422992/
Abstract

Data were collected from 39 newborn screening (NBS) programs to provide insight into the time and factors required for implementing statewide screening for Pompe, Mucopolysaccharidosis type I (MPS I), adrenoleukodystrophy (ALD), and Spinal Muscular Atrophy (SMA). Newborn screening program readiness to screen statewide for a condition was assessed using four phases: (1) approval to screen; (2) laboratory, follow-up, and information technology capabilities; (3) education; and (4) implementation of statewide newborn screening. Seventeen states (43.6%) reached statewide implementation for at least one new disorder. Those states reported that it took 28 months to implement statewide screening for Pompe and MPS I, 30.5 months for ALD, and 20 months for SMA. Using survival curve analysis to account for states still in progress, the estimated median time to statewide screening increased to 75 months for Pompe and 66 months for MPS I. When looking at how long each readiness component took to complete, laboratory readiness was one of the lengthier processes, taking about 39 months. Collaboration with other NBS programs and hiring were the most frequently mentioned facilitators to implementing newborn screening. Staffing or inability to hire both laboratory and follow-up staff was the most frequently mentioned barrier.

摘要

从39个新生儿筛查(NBS)项目收集数据,以深入了解在全州范围内开展庞贝氏病、I型黏多糖贮积症(MPS I)、肾上腺脑白质营养不良(ALD)和脊髓性肌萎缩症(SMA)筛查所需的时间和因素。使用四个阶段评估新生儿筛查项目在全州范围内针对某一病症进行筛查的准备情况:(1)筛查批准;(2)实验室、随访和信息技术能力;(3)教育;(4)全州新生儿筛查的实施。17个州(43.6%)至少针对一种新病症实现了全州范围的实施。这些州报告称,在全州范围内实施庞贝氏病和MPS I筛查耗时28个月,ALD筛查耗时30.5个月,SMA筛查耗时20个月。使用生存曲线分析来考虑仍在进行中的州,庞贝氏病全州筛查的估计中位时间增加到75个月,MPS I为66个月。在查看每个准备阶段完成所需的时间时,实验室准备是耗时较长的过程之一,约需39个月。与其他NBS项目的合作和招聘是实施新生儿筛查最常提到的促进因素。人员配备不足或无法招聘实验室和随访工作人员是最常提到的障碍。

相似文献

1
Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences.实施全州范围针对新疾病的新生儿筛查:美国项目经验
Int J Neonatal Screen. 2020 Apr 30;6(2):35. doi: 10.3390/ijns6020035. eCollection 2020 Jun.
2
Implementation of Newborn Screening for Conditions in the United States First Recommended during 2010-2018.2010 - 2018年期间首次建议在美国开展的针对特定病症的新生儿筛查实施情况。
Int J Neonatal Screen. 2023 Apr 6;9(2):20. doi: 10.3390/ijns9020020.
3
Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation.在美国扩大庞贝病新生儿筛查:新步骤新疾病实施项目,新疾病实施的资源。
Int J Neonatal Screen. 2020 Jun 11;6(2):48. doi: 10.3390/ijns6020048. eCollection 2020 Jun.
4
A Historical and Current Review of Newborn Screening for Neuromuscular Disorders From Around the World: Lessons for the United States.全球范围内神经肌肉疾病新生儿筛查的历史和现状回顾:对美国的启示。
Pediatr Neurol. 2017 Dec;77:12-22. doi: 10.1016/j.pediatrneurol.2017.08.012. Epub 2017 Aug 25.
5
Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelines.纽约州X连锁肾上腺脑白质营养不良的新生儿筛查:诊断方案、监测方案及治疗指南。
Mol Genet Metab. 2015 Apr;114(4):599-603. doi: 10.1016/j.ymgme.2015.02.002. Epub 2015 Feb 12.
6
Evaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina.北卡罗来纳州 X 连锁肾上腺脑白质营养不良新生儿筛查评估。
JAMA Netw Open. 2020 Jan 3;3(1):e1920356. doi: 10.1001/jamanetworkopen.2019.20356.
7
A Voluntary Statewide Newborn Screening Pilot for Spinal Muscular Atrophy: Results from Early Check.一项全州范围内自愿进行的脊髓性肌萎缩症新生儿筛查试点:早期检查结果。
Int J Neonatal Screen. 2021 Mar 21;7(1):20. doi: 10.3390/ijns7010020.
8
The implementation of newborn screening for spinal muscular atrophy: the Australian experience.脊髓性肌萎缩症新生儿筛查的实施:澳大利亚的经验。
Genet Med. 2020 Mar;22(3):557-565. doi: 10.1038/s41436-019-0673-0. Epub 2019 Oct 14.
9
Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.溶酶体贮积症筛查实施情况:密苏里州全面人群试点测试头六个月的发现。
J Pediatr. 2015 Jan;166(1):172-7. doi: 10.1016/j.jpeds.2014.09.023. Epub 2014 Oct 18.
10
Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.Duchenne 型肌营养不良症和脊髓性肌萎缩症的治疗和新生儿筛查进展。
World J Pediatr. 2019 Jun;15(3):219-225. doi: 10.1007/s12519-019-00242-6. Epub 2019 Mar 23.

引用本文的文献

1
Outcomes of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in the Valencian Community.巴伦西亚自治区脊髓性肌萎缩症新生儿筛查试点项目的成果
Int J Neonatal Screen. 2025 Jan 14;11(1):7. doi: 10.3390/ijns11010007.
2
Integrated Approaches and Practical Recommendations in Patient Care Identified with 5q Spinal Muscular Atrophy through Newborn Screening.通过新生儿筛查鉴定 5q 型脊髓性肌萎缩症患者的综合治疗方法和实用建议。
Genes (Basel). 2024 Jun 29;15(7):858. doi: 10.3390/genes15070858.
3
Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).

本文引用的文献

1
Analyzing Patterns in NewSTEPs Site Review Recommendations: Practical Applications for Newborn Screening Programs.分析新生儿筛查与跟踪电子项目(NewSTEPs)现场评审建议中的模式:新生儿筛查项目的实际应用
Int J Neonatal Screen. 2019 Feb 12;5(1):13. doi: 10.3390/ijns5010013. eCollection 2019 Mar.
2
NewSTEPs: The Establishment of a National Newborn Screening Technical Assistance Resource Center.新生儿筛查新步骤:国家新生儿筛查技术援助资源中心的设立
Int J Neonatal Screen. 2017 Dec 22;4(1):1. doi: 10.3390/ijns4010001. eCollection 2018 Mar.
3
The REDCap consortium: Building an international community of software platform partners.
《2024年全球新生儿血斑筛查现状:2020 - 2023年近期活动综合回顾》
Int J Neonatal Screen. 2024 May 23;10(2):38. doi: 10.3390/ijns10020038.
4
Establishment of Age Specific Reference Interval for Aminoacids and Acylcarnitine in Dried Blood Spot by Tandem Mass Spectrometry.采用串联质谱法建立干血斑中氨基酸和酰基肉碱的年龄特异性参考区间
Indian J Clin Biochem. 2024 Apr;39(2):233-240. doi: 10.1007/s12291-023-01128-1. Epub 2023 Mar 9.
5
Infants with Congenital Diseases Identified through Newborn Screening-United States, 2018-2020.2018 - 2020年美国通过新生儿筛查确诊的先天性疾病患儿
Int J Neonatal Screen. 2023 Apr 13;9(2):23. doi: 10.3390/ijns9020023.
6
Implementation of Newborn Screening for Conditions in the United States First Recommended during 2010-2018.2010 - 2018年期间首次建议在美国开展的针对特定病症的新生儿筛查实施情况。
Int J Neonatal Screen. 2023 Apr 6;9(2):20. doi: 10.3390/ijns9020020.
7
Current Postlaunch Implementation of State Mandates of Newborn Screening for Critical Congenital Heart Disease by Pulse Oximetry in U.S. States and Hospitals.美国各州和医院通过脉搏血氧仪对新生儿进行关键型先天性心脏病的强制性筛查的最新实施情况。
Am J Perinatol. 2024 May;41(S 01):e550-e562. doi: 10.1055/s-0042-1756327. Epub 2022 Dec 29.
8
A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes.一种客观评估遗传性代谢疾病以纳入新生儿筛查项目的新方法。
Int J Neonatal Screen. 2022 Mar 25;8(2):25. doi: 10.3390/ijns8020025.
9
Preparing newborn screening for the future: a collaborative stakeholder engagement exploring challenges and opportunities to modernizing the newborn screening system.为未来做好新生儿筛查准备:合作利益相关者参与探索现代化新生儿筛查系统所面临的挑战和机遇。
BMC Pediatr. 2022 Feb 12;22(1):90. doi: 10.1186/s12887-021-03035-x.
10
Expert Evaluation of Strategies to Modernize Newborn Screening in the United States.美国新生儿筛查现代化策略的专家评估。
JAMA Netw Open. 2021 Dec 1;4(12):e2140998. doi: 10.1001/jamanetworkopen.2021.40998.
REDCap 联盟:构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
4
Delay in State Adoption of Newborn Screening Tests.各州采用新生儿筛查测试的延迟。
Pediatrics. 2018 Jan;141(1). doi: 10.1542/peds.2017-0300. Epub 2017 Dec 20.
5
State Newborn Health Screening Policies.国家新生儿健康筛查政策。
NCSL Legisbrief. 2017 Apr;25(14):1-2.
6
Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children.被提名列入推荐统一筛查小组的条件的决策过程:美国卫生与公众服务部部长遗传性新生儿和儿童疾病咨询委员会的声明。
Genet Med. 2014 Feb;16(2):183-7. doi: 10.1038/gim.2013.98. Epub 2013 Aug 1.
7
Ten great public health achievements--United States, 2001-2010.十个重大公共卫生成就——美国,2001-2010 年。
MMWR Morb Mortal Wkly Rep. 2011 May 20;60(19):619-23.
8
Expanded newborn screening: reducing harm, assessing benefit.扩大新生儿筛查:减少伤害,评估获益。
J Inherit Metab Dis. 2010 Oct;33(Suppl 2):S205-10. doi: 10.1007/s10545-010-9106-6. Epub 2010 May 4.
9
Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children.委员会报告:用于评估新生儿和儿童人群筛查候选条件的方法。
Genet Med. 2010 Mar;12(3):153-9. doi: 10.1097/GIM.0b013e3181d2af04.
10
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.研究电子数据采集(REDCap)——一种用于提供转化研究信息学支持的元数据驱动方法和工作流程。
J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.